TruPlex HIV/HepB/Syphilis Rapid Test performance and usability in real-world settings

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study evaluates the clinical performance of the TruPlex HIV/HepB/Syphilis Rapid Test for detecting HIV, Hepatitis B surface antigen, and syphilis. It uses capillary fingerstick blood, EDTA whole blood, EDTA plasma, and SST serum collected by trained operators at point-of-care settings. Additional venous samples are sent for confirmatory testing with approved on-the-market assays, and remaining samples may be stored for future research or discrepancy testing. The study also assesses usability through structured questionnaires completed by trained operators in real-world settings. Analytes are tested across sample types to determine performance and practicality of implementation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age or older
* Subject is able to provide and willing to sign and date the Informed Consent Form
* Subject is able to complete the required testing on the allocated testing day.
* Subject is able to speak/read/write English or a translator is available
* Subject is getting tested for HIV, and/or Syphilis, and/or Hepatitis B for one or more of the following reasons:

  * At risk for any one of the target diseases
  * Having signs or symptoms indicative of the target diseases
  * Routine testing
  * Note: Subjects who are pregnant and re-infected are eligible to participate
* Unknown HIV or known HIV positive status with less than 12 months of Anti-Retroviral Treatment (ART).
* Subject is willing to provide the fingerstick blood sample(s) and whole blood samples collected through venous blood draw (approximately 16 ml) required for the study.
* Subject willing to participate in the study site's standard of care counselling and testing program and receive the study site's standard of care test results

Exclusion Criteria:

* Subject has a bleeding disorder
* Subject is currently undergoing Syphilis treatment
* Subject has received any experimental HIV vaccine
* Subject received HBV vaccine within the last 7 days
* Known HIV positive subjects and currently on ART for 12 months or longer
* Any condition which, in the opinion of the Investigator, would make the participant unsuitable or unsafe for enrolment or could interfere with the completion of study assessment, consent form and questionnaire etc. or bias the study outcome.

Where it's running

• St Vincent's Hospital (Melbourne), Dept. of Gastroenterology
  Melbourne, Victoria, Australia Recruiting

Study contacts

• Study coordinator: Ana Subramanian
• Email: asubramanian@biolytical.com
• Phone: 16042046784

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TruPlex rapid test for HIV, Hepatitis B, and syphilis performance and usability

  This project will test whether the TruPlex rapid test can accurately detect HIV, hepatitis B, and syphilis when used by trained healthcare workers on adults getting tested for these infections.

  Recruiting at 3 sites bioLytical Laboratories · Johannesburg, Gauteng and 2 other locations · NCT07563309

• Doxycycline after sex to prevent gonorrhea, chlamydia, and syphilis in MSM in Bangkok

  This research tests whether taking doxycycline after sex can prevent gonorrhea, chlamydia, and syphilis in men who have sex with men in Bangkok.

  Recruiting Phase 4 Bangrak STIs Center · Sathorn, Bangkok · NCT07397403

• Rapid syphilis testing at family planning visits in Hawai‘i

  This study checks if a quick fingerstick syphilis test done during a family planning visit is practical and acceptable for patients.

  Recruiting Queen's Medical Center · Honolulu, Hawaii · NCT07358949

• New ALPCO blood tests to detect syphilis antibodies

  This will test two ALPCO blood tests that look for treponemal and non-treponemal antibodies in people screened for or suspected of having syphilis, including pregnant and HIV-positive individuals.

  Recruiting at 6 sites American Laboratory Products Company · Lancaster, California and 5 other locations · NCT07089836

• Multiplo HIV and syphilis self-test for adults

  This project will see if adults seeking HIV or syphilis testing can correctly use the Multiplo HIV/syphilis self-test to get accurate results.

  Recruiting at 3 sites Unity Health Toronto · Victoria, British Columbia and 2 other locations · NCT06716450

• Using lidocaine to reduce pain from benzathine penicillin injections for syphilis treatment

  This study is testing if adding lidocaine to syphilis treatment injections can help reduce the pain patients feel during and after the shot.

  Recruiting Phase 3 Washington University School of Medicine · St Louis, Missouri · NCT06391125

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.